HIV pediatric classification system

Revision as of 01:06, 11 June 2012 by WikiBot (talk | contribs)
Jump to navigation Jump to search

Sexually transmitted diseases Main Page

AIDS Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating AIDS from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

HIV Opportunistic Infections

HIV Coinfections

HIV and Pregnancy

HIV Infection in Infants

Diagnosis

Diagnostic Study of Choice

AIDS Case Definition

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Nutrition
Drug Resistance

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

HIV Vaccine

Case Studies

Case #1

HIV pediatric classification system On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV pediatric classification system

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV pediatric classification system

CDC on HIV pediatric classification system

HIV pediatric classification system in the news

Blogs on HIV pediatric classification system

Directions to Hospitals Treating AIDS

Risk calculators and risk factors for HIV pediatric classification system

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-In-Chief: Ujjwal Rastogi, M.B.B.S. [2]

Overview

Additional knowledge of the progression of HIV disease among children lead to the development of revised classification system for HIV infection in children in 1994 which replaced the pediatric HIV classification system that was published earlier in 1987.

Pediatric Classification System

Category N: Not Symptomatic
Children who have no signs or symptoms considered to be the result of HIV infection or who have only one of the conditions listed in category A.
Category A: Mildly Symptomatic
Children with two or more of the following conditions but none of the conditions listed in Categories B and C:
Lymphadenopathy (≥0.5 cm at more than two sites; bilateral = one site)
Hepatomegaly
Splenomegaly
Dermatitis
Parotitis
Recurrent or persistent upper respiratory infection, sinusitis, or otitis media
Category B: Moderately Symptomatic
Children who have symptomatic conditions, other than those listed for Category A or Category C, that are attributed to HIV infection. Examples of conditions in Clinical Category B include, but are not limited to, the following:
Anemia (<8 gm/dL), neutropenia (<1,000 cells/mm3), or thrombocytopenia (<100,000 cells/mm3) persisting ≥30 days.
Bacterial meningitis, pneumonia, or sepsis (single episode)
Candidiasis, oropharyngeal (i.e., thrush) persisting for >2 months in children age >6 months
Cardiomyopathy
Cytomegalovirus infection with onset before age 1 month
Diarrhea, recurrent or chronic
Hepatitis
Herpes simplex virus (HSV) stomatitis, recurrent (i.e., more than two episodes within 1 year)
HSV bronchitis, pneumonitis, or esophagitis with onset before age 1 month
Herpes zoster (i.e., shingles) involving at least two distinct episodes or more than one dermatome
Leiomyosarcoma
Lymphoid interstitial pneumonia (LIP) or pulmonary lymphoid hyperplasia complex
Nocardiosis
Fever lasting >1 month
Toxoplasmosis with onset before age 1 month
Varicella, disseminated (i.e., complicated chickenpox)
Category C: Severely Symptomatic
Children who have any condition listed in the 1987 surveillance case definition for acquired immunodeficiency synd­rome (below), with the exception of LIP (which is a Category B condition):
Serious bacterial infections, multiple or recurrent (i.e., any combination of at least two culture-confirmed infections within a 2-year period), of the following types: septicemia, pneumonia, meningitis, bone or joint infection, or abscess of an internal organ or body cavity (excluding otitis media, superficial skin or mucosal abscesses, and indwelling catheter-related infections)
Candidiasis, esophageal or pulmonary (bronchi, trachea, lungs)
Coccidioidomycosis, disseminated (at site other than or in addition to lungs or cervical or hilar lymph nodes)
Cryptococcosis, extrapulmonary
Cryptosporidiosis or isosporiasis with diarrhea persisting >1 month
Encephalopathy (at least one of the following progressive findings present for at least 2 months in the absence of a concurrent illness other than HIV infection that could explain the findings)
a) failure to attain or loss of develop­mental milestones or loss of intellectual ability, verified by standard developmental scale or neuropsychological tests;
b) impaired brain growth or acquired microcephaly demonstrated by head circumference measurements or brain atrophy demonstrated by computerized tomography or magnetic resonance imaging (serial imaging is re­quired for children <2 years of age);
c) acquired symmetric motor deficit manifested by two or more of the follow­ing:paresis, pathologic reflexes, ataxia, or gait disturbance
Herpes simplex virus infection causing a mucocutaneous ulcer that persists for >1 month or bronchitis, pneumoni­tis, or esophagitis for any duration affecting a child >1 month of age
Histoplasmosis, disseminated (at a site other than or in addition to lungs or cervical or hilar lymph nodes)
Kaposi's sarcoma
Lymphoma, primary, in brain
Lymphoma, small, noncleaved cell (Burkitt's), or immunoblastic or large cell lymphoma of B-cell or unknown im­munologic phenotype
Mycobacterium tuberculosis, disseminated or extrapulmonary
Mycobacterium, other species or unidentified species, disseminated (at a site other than or in addition to lungs, skin, or cervical or hilar lymph nodes)
Mycobacterium avium complex or Mycobacterium kansasii, disseminated (at site other than or in addition to lungs, skin, or cervical or hilar lymph nodes)
Pneumocystis jiroveci pneumonia
Progressive multifocal leukoencephalopathy
Salmonella (nontyphoid) septicemia, recurrent
Toxoplasmosis of the brain with onset at >1 month of age
Wasting syndrome in the absence of a concurrent illness other than HIV infection that could explain the following findings:
a) persistent weight loss >10% of baseline; OR
b) downward crossing of at least two of the following percentile lines on the weight-for-age chart (e.g., 95th, 75th, 50th, 25th, 5th) in a child ≥1 year of age; OR
c) <5th per­centile on weight-for-height chart on two consecutive measurements, ≥30 days apart PLUS 1) chronic diarrhea (i.e., ≥ two loose stools per day for >30 days), OR 2) documented fever (for ≥30 days, intermittent or constant)